"ono pharm" - Google News

Limited Submission Opportunity: 2026 Ono Pharma Breakthrough Science Initiative Awards - Vanderbilt University

Wed, 10 Dec 2025 08:00:00 GMT

Limited Submission Opportunity: 2026 Ono Pharma Breakthrough Science Initiative Awards Vanderbilt University

Congruence and Ono Pharma Expand Multi-Target Research Partnership with the Addition of Two New Programs - PR Newswire

Mon, 02 Mar 2026 08:00:00 GMT

Congruence and Ono Pharma Expand Multi-Target Research Partnership with the Addition of Two New Programs PR Newswire

Ono Pharma Announces Oral Presentation of New Data from the Phase 2 Clinical Study of ONO-4578 (EP4 antagonist) in Certain Gastric Cancers at the ASCO 2026 Annual Meeting - BioSpace

Tue, 02 Jun 2026 07:03:56 GMT

Ono Pharma Announces Oral Presentation of New Data from the Phase 2 Clinical Study of ONO-4578 (EP4 antagonist) in Certain Gastric Cancers at the ASCO 2026 Annual Meeting BioSpace

Message from the COO | Corporate Reports | IR Library | Investors | ONO PHARMACEUTICAL CO., LTD. - ono-pharma.com

Wed, 01 Oct 2025 22:43:18 GMT

Message from the COO | Corporate Reports | IR Library | Investors | ONO PHARMACEUTICAL CO., LTD. ono-pharma.com

Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 (S1P5 Receptor Agonist) in Multiple System Atrophy at the 7th World Parkinson Congress (WPC) - Business Wire

Wed, 27 May 2026 07:00:00 GMT

Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 (S1P5 Receptor Agonist) in Multiple System Atrophy at the 7th World Parkinson Congress (WPC) Business Wire

Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology - Yahoo Finance

Mon, 02 Mar 2026 08:00:00 GMT

Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology Yahoo Finance

Ono’s Deciphera drops early-stage solid tumor drug for strategic reasons - Fierce Biotech

Tue, 03 Mar 2026 08:00:00 GMT

Ono’s Deciphera drops early-stage solid tumor drug for strategic reasons Fierce Biotech

Ono Pharmaceutical And Congruence Expand Research Alliance Into Neurology And Immunology - BioPharma APAC

Sun, 17 May 2026 05:56:28 GMT

Ono Pharmaceutical And Congruence Expand Research Alliance Into Neurology And Immunology BioPharma APAC

TMEM175 activators reported in Ono Pharmaceutical patent - BioWorld News

Thu, 30 Apr 2026 07:00:00 GMT

TMEM175 activators reported in Ono Pharmaceutical patent BioWorld News

LigaChem secures additional milestone payment from Ono Pharma for ADC collaboration - koreabiomed.com

Fri, 27 Feb 2026 08:00:00 GMT

LigaChem secures additional milestone payment from Ono Pharma for ADC collaboration koreabiomed.com

Ono Pharma files for approval of ripretinib in Japan - The Pharma Letter

Thu, 26 Mar 2026 07:00:00 GMT

Ono Pharma files for approval of ripretinib in Japan The Pharma Letter

Ono Pharma Announces Upcoming Presentations at the ASCO 2026 Annual Meeting - Business Wire

Tue, 21 Apr 2026 07:00:00 GMT

Ono Pharma Announces Upcoming Presentations at the ASCO 2026 Annual Meeting Business Wire

Message from the CEO | Corporate Reports | IR Library | Investors | ONO PHARMACEUTICAL CO., LTD. - ono-pharma.com

Thu, 02 Oct 2025 01:26:05 GMT

Message from the CEO | Corporate Reports | IR Library | Investors | ONO PHARMACEUTICAL CO., LTD. ono-pharma.com

Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical - Yahoo Finance

Wed, 07 Jan 2026 08:00:00 GMT

Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical Yahoo Finance

Sinopia Biosciences Announces Target Discovery Collaboration with Ono Pharmaceutical for Rare Metabolic Disorders - BioSpace

Tue, 03 Mar 2026 08:00:00 GMT

Sinopia Biosciences Announces Target Discovery Collaboration with Ono Pharmaceutical for Rare Metabolic Disorders BioSpace

PRISM BioLab Achieved Initial Milestone and Receives the Milestone Payment in Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd. - PR Newswire

Fri, 14 Nov 2025 08:00:00 GMT

PRISM BioLab Achieved Initial Milestone and Receives the Milestone Payment in Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd. PR Newswire

LigaChem earns milestone payment from Ono Pharma for ADC platform transfer - koreabiomed.com

Thu, 08 Jan 2026 08:00:00 GMT

LigaChem earns milestone payment from Ono Pharma for ADC platform transfer koreabiomed.com

Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan - Business Wire

Thu, 26 Mar 2026 07:00:00 GMT

Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan Business Wire

STORY03 | ONO Pharmaceutical’s corporate slogan: BREAK THROUGH" | About | ONO PHARMACEUTICAL CO., LTD. - ono-pharma.com

Mon, 01 Sep 2025 09:08:12 GMT

STORY03 | ONO Pharmaceutical’s corporate slogan: BREAK THROUGH" | About | ONO PHARMACEUTICAL CO., LTD. ono-pharma.com

Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory PCNSL - Business Wire

Tue, 17 Feb 2026 08:00:00 GMT

Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory PCNSL Business Wire

Ono Pharma’s tirabrutinib accelerated NDA accepted by FDA - The Pharma Letter

Mon, 16 Feb 2026 08:00:00 GMT

Ono Pharma’s tirabrutinib accelerated NDA accepted by FDA The Pharma Letter

Ono's BMS-partnered EP4 antagonist improves progression-free survival in phase 2 gastric cancer test - Fierce Biotech

Thu, 09 Oct 2025 07:00:00 GMT

Ono's BMS-partnered EP4 antagonist improves progression-free survival in phase 2 gastric cancer test Fierce Biotech

Deciphera Announces the Opening of a New Office in Zug, Switzerland - Business Wire

Mon, 17 Nov 2025 08:00:00 GMT

Deciphera Announces the Opening of a New Office in Zug, Switzerland Business Wire

Ono Pharma Opens New Office in Zug, Switzerland - Contract Pharma

Mon, 17 Nov 2025 08:00:00 GMT

Ono Pharma Opens New Office in Zug, Switzerland Contract Pharma

ONO Receives Highest A-List Rating in CDP 2024 Report for Climate Change and Water Security Efforts - ono-pharma.com

Tue, 29 Jul 2025 07:00:00 GMT

ONO Receives Highest A-List Rating in CDP 2024 Report for Climate Change and Water Security Efforts ono-pharma.com

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting - Business Wire

Sat, 06 Dec 2025 08:00:00 GMT

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting Business Wire

Ono Pharma Reports Positive Phase 2 Signals for ONO-2808 in Multiple System Atrophy - BioPharma APAC

Sun, 12 Oct 2025 20:23:28 GMT

Ono Pharma Reports Positive Phase 2 Signals for ONO-2808 in Multiple System Atrophy BioPharma APAC

Deciphera Announces Multiple Data Presentations at the Connective Tissue Oncology Society (CTOS) Annual Meeting 2025 - Business Wire

Wed, 12 Nov 2025 08:00:00 GMT

Deciphera Announces Multiple Data Presentations at the Connective Tissue Oncology Society (CTOS) Annual Meeting 2025 Business Wire

Monash University and Ono Pharmaceutical sign two licence agreements - Monash University

Fri, 13 Feb 2026 08:00:00 GMT

Monash University and Ono Pharmaceutical sign two licence agreements Monash University

SK biopharmaceuticals’ partner Ono files NDA for epilepsy drug cenobamate in Japan - koreabiomed.com

Wed, 01 Oct 2025 07:00:00 GMT

SK biopharmaceuticals’ partner Ono files NDA for epilepsy drug cenobamate in Japan koreabiomed.com

Fierce Pharma Asia—TROP2 showdown; InnoCare, Zenas' $2B autoimmune deal; Lupin's US investment - Fierce Pharma

Fri, 10 Oct 2025 07:00:00 GMT

Fierce Pharma Asia—TROP2 showdown; InnoCare, Zenas' $2B autoimmune deal; Lupin's US investment Fierce Pharma

STORY02 | ONO Pharmaceutical’s corporate slogan: BREAK THROUGH" | About | ONO PHARMACEUTICAL CO., LTD. - ono-pharma.com

Tue, 01 Oct 2024 03:29:32 GMT

STORY02 | ONO Pharmaceutical’s corporate slogan: BREAK THROUGH" | About | ONO PHARMACEUTICAL CO., LTD. ono-pharma.com

MSS forges Korea-Japan pharma R&D pact as Astellas, Maruho, Ono join - CHOSUNBIZ - Chosunbiz

Thu, 26 Feb 2026 08:00:00 GMT

MSS forges Korea-Japan pharma R&D pact as Astellas, Maruho, Ono join - CHOSUNBIZ Chosunbiz

Harvard and ONO Pharmaceutical Launch University-Wide Alliance to Address Multiple Disease Areas - Harvard Office of Technology Development

Mon, 11 Mar 2024 07:00:00 GMT

Harvard and ONO Pharmaceutical Launch University-Wide Alliance to Address Multiple Disease Areas Harvard Office of Technology Development

STORY01 | ONO Pharmaceutical’s corporate slogan: BREAK THROUGH" | About | ONO PHARMACEUTICAL CO., LTD. - ono-pharma.com

Tue, 01 Oct 2024 03:28:26 GMT

STORY01 | ONO Pharmaceutical’s corporate slogan: BREAK THROUGH" | About | ONO PHARMACEUTICAL CO., LTD. ono-pharma.com

Ono Pharmaceutical outlines post-Opdivo growth strategy, deepening partnerships with NEX-I, LigaChem Biosciences, and SK Biopharm - 더바이오

Tue, 20 Jan 2026 08:00:00 GMT

Ono Pharmaceutical outlines post-Opdivo growth strategy, deepening partnerships with NEX-I, LigaChem Biosciences, and SK Biopharm 더바이오

Ono Pharma lays off 83 staffers at Cambridge, Massachusetts, site - Fierce Biotech

Tue, 29 Apr 2025 07:00:00 GMT

Ono Pharma lays off 83 staffers at Cambridge, Massachusetts, site Fierce Biotech

Notice about the Establishment of the ONO PHARMA Heritage Center - ono-pharma.com

Fri, 14 Mar 2025 07:00:00 GMT

Notice about the Establishment of the ONO PHARMA Heritage Center ono-pharma.com

ONO PHARMA USA Announces 2025 Golden Ticket CompetitionNow Accepting Applications from Innovative Startups - PR Newswire

Sat, 26 Apr 2025 07:00:00 GMT

ONO PHARMA USA Announces 2025 Golden Ticket CompetitionNow Accepting Applications from Innovative Startups PR Newswire

Ono’s FDA Rare Cancer Approval Sets Up Face Off With Daiichi Sankyo - BioSpace

Mon, 17 Feb 2025 08:00:00 GMT

Ono’s FDA Rare Cancer Approval Sets Up Face Off With Daiichi Sankyo BioSpace

FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout - Fierce Pharma

Fri, 14 Feb 2025 08:00:00 GMT

FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout Fierce Pharma

Fierce Pharma Asia—Akeso bispecific's first survival readout; AstraZeneca's China probes; Ono's layoffs - Fierce Pharma

Fri, 02 May 2025 07:00:00 GMT

Fierce Pharma Asia—Akeso bispecific's first survival readout; AstraZeneca's China probes; Ono's layoffs Fierce Pharma

Ono Pharma Drug Acquired in $2.4B Deal Wins FDA Approval for Treating Rare Type of Tumor - MedCity News

Tue, 18 Feb 2025 08:00:00 GMT

Ono Pharma Drug Acquired in $2.4B Deal Wins FDA Approval for Treating Rare Type of Tumor MedCity News

Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Owned Subsidiary of Ono) - PR Newswire

Tue, 11 Jun 2024 07:00:00 GMT

Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Owned Subsidiary of Ono) PR Newswire

ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals - PR Newswire

Tue, 30 Apr 2024 07:00:00 GMT

ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals PR Newswire

Ono earmarks $940m to gain rare blood cancer therapy from Ionis - Pharmaceutical Technology

Wed, 12 Mar 2025 07:00:00 GMT

Ono earmarks $940m to gain rare blood cancer therapy from Ionis Pharmaceutical Technology

Ono pays $280M to license Ionis rare disease drug - BioPharma Dive

Wed, 12 Mar 2025 07:00:00 GMT

Ono pays $280M to license Ionis rare disease drug BioPharma Dive

Ono Pharmaceutical to acquire Deciphera Pharma, maker of cancer drugs, for $2.4 billion - statnews.com

Mon, 29 Apr 2024 07:00:00 GMT

Ono Pharmaceutical to acquire Deciphera Pharma, maker of cancer drugs, for $2.4 billion statnews.com

Where Are They Now? Ono Pharmaceuticals - Life Science Leader

Mon, 05 Feb 2024 08:00:00 GMT

Where Are They Now? Ono Pharmaceuticals Life Science Leader

Ono pays $280M upfront for Ionis' antisense oligonucleotide for rare blood cancer - Fierce Biotech

Wed, 12 Mar 2025 07:00:00 GMT

Ono pays $280M upfront for Ionis' antisense oligonucleotide for rare blood cancer Fierce Biotech

Ionis and Ono announce global license agreement for sapablursen in polycythemia vera - Business Wire

Tue, 11 Mar 2025 07:00:00 GMT

Ionis and Ono announce global license agreement for sapablursen in polycythemia vera Business Wire

Fierce Pharma Asia—Takeda's oncology focus; Sun's Checkpoint buy; Ono-Ionis antisense deal - Fierce Pharma

Fri, 14 Mar 2025 07:00:00 GMT

Fierce Pharma Asia—Takeda's oncology focus; Sun's Checkpoint buy; Ono-Ionis antisense deal Fierce Pharma

Ono links with LigaChem to bag preclinical ADC in $700M biobuck deal - Fierce Biotech

Thu, 10 Oct 2024 07:00:00 GMT

Ono links with LigaChem to bag preclinical ADC in $700M biobuck deal Fierce Biotech

Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn - Pharmaceutical Technology

Mon, 29 Apr 2024 07:00:00 GMT

Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn Pharmaceutical Technology

Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion - Business Wire

Mon, 29 Apr 2024 07:00:00 GMT

Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion Business Wire

Ono’s TGCT therapy wins FDA approval, challenging Daiichi Sankyo - Pharmaceutical Technology

Mon, 17 Feb 2025 08:00:00 GMT

Ono’s TGCT therapy wins FDA approval, challenging Daiichi Sankyo Pharmaceutical Technology

Support for Assessing Therapeutic Efficacy in Patients with Inflammatory Bowel Disease through Unstructured Data in Electronic Health Records - NTT Data

Thu, 16 Jan 2025 18:42:49 GMT

Support for Assessing Therapeutic Efficacy in Patients with Inflammatory Bowel Disease through Unstructured Data in Electronic Health Records NTT Data

Japan's Ono pays $2.4B for Qinlock maker Deciphera as biotech readies another approval run - Fierce Pharma

Mon, 29 Apr 2024 07:00:00 GMT

Japan's Ono pays $2.4B for Qinlock maker Deciphera as biotech readies another approval run Fierce Pharma

PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono - PR Newswire

Thu, 25 Apr 2024 07:00:00 GMT

PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono PR Newswire

Ono Acquires Deciphera Pharmaceuticals - Contract Pharma

Wed, 12 Jun 2024 07:00:00 GMT

Ono Acquires Deciphera Pharmaceuticals Contract Pharma

Caris Life Sciences and Ono Pharmaceutical Announce Strategic Collaboration Leveraging Caris' Novel, Blood-Based cNAS Molecular Profiling Assay Across Several Ono Clinical Studies - PR Newswire

Thu, 14 Oct 2021 07:00:00 GMT

Caris Life Sciences and Ono Pharmaceutical Announce Strategic Collaboration Leveraging Caris' Novel, Blood-Based cNAS Molecular Profiling Assay Across Several Ono Clinical Studies PR Newswire

Ono Pharmaceutical to Acquire Deciphera for $2.4B - Contract Pharma

Mon, 29 Apr 2024 07:00:00 GMT

Ono Pharmaceutical to Acquire Deciphera for $2.4B Contract Pharma

Ono to Buy Deciphera for $2.4B, Looks to Expand Cancer Pipeline and US Footprint - BioSpace

Mon, 29 Apr 2024 07:00:00 GMT

Ono to Buy Deciphera for $2.4B, Looks to Expand Cancer Pipeline and US Footprint BioSpace

Fierce Pharma Asia—Novo Nordisk's fraud accusation; AstraZeneca's China deal; Ono's FDA nod - Fierce Pharma

Fri, 21 Feb 2025 08:00:00 GMT

Fierce Pharma Asia—Novo Nordisk's fraud accusation; AstraZeneca's China deal; Ono's FDA nod Fierce Pharma

Pharm Sci’s Robert Spitale wins Ono Pharma Breakthrough Science Initiative Award - UC Irvine News

Fri, 12 Jul 2019 07:00:00 GMT

Pharm Sci’s Robert Spitale wins Ono Pharma Breakthrough Science Initiative Award UC Irvine News

Ono Pharmaceutical Partners with InveniAI to Revolutionize Drug Discovery Using AI - BioPharma APAC

Thu, 22 Feb 2024 08:00:00 GMT

Ono Pharmaceutical Partners with InveniAI to Revolutionize Drug Discovery Using AI BioPharma APAC

KSQ scores 'double-digit million' payment from Japan's Ono for preclinical cancer programs - Fierce Biotech

Wed, 25 Jan 2023 08:00:00 GMT

KSQ scores 'double-digit million' payment from Japan's Ono for preclinical cancer programs Fierce Biotech

ONO PHARMA USA Announces 2023 Golden Ticket Competition in Partnership with LabCentral and MBC BioLabs - PR Newswire

Tue, 18 Apr 2023 07:00:00 GMT

ONO PHARMA USA Announces 2023 Golden Ticket Competition in Partnership with LabCentral and MBC BioLabs PR Newswire

Pharma company announces it will lay off 83 Boston-area employees - Boston.com

Tue, 29 Apr 2025 07:00:00 GMT

Pharma company announces it will lay off 83 Boston-area employees Boston.com

Greenberg, Goodwin shepherd Ono Pharma’s $2.4bn Deciphera acquisition - The Global Legal Post

Tue, 30 Apr 2024 07:00:00 GMT

Greenberg, Goodwin shepherd Ono Pharma’s $2.4bn Deciphera acquisition The Global Legal Post

Ono's ROMVIMZA Approval Shakes Up Tenosynovial Giant Cell Tumors Market, Challenging Daiichi Sankyo's TURALIO Dominance | DelveInsight - PR Newswire

Tue, 04 Mar 2025 08:00:00 GMT

Ono's ROMVIMZA Approval Shakes Up Tenosynovial Giant Cell Tumors Market, Challenging Daiichi Sankyo's TURALIO Dominance | DelveInsight PR Newswire

Ono Pharma licenses ADCs from LigaChem - The Pharma Letter

Thu, 10 Oct 2024 07:00:00 GMT

Ono Pharma licenses ADCs from LigaChem The Pharma Letter

Monash University and Ono Pharmaceutical continue collaboration agreement - Monash University

Thu, 01 Aug 2024 07:00:00 GMT

Monash University and Ono Pharmaceutical continue collaboration agreement Monash University

The top 10 biopharma M&A deals of 2024 - Fierce Pharma

Mon, 13 Jan 2025 08:00:00 GMT

The top 10 biopharma M&A deals of 2024 Fierce Pharma

Japan's Ono Pharma inks $700 M ADC deal with Korean firm LigaChem Biosciences - BioSpectrum Asia

Mon, 14 Oct 2024 07:00:00 GMT

Japan's Ono Pharma inks $700 M ADC deal with Korean firm LigaChem Biosciences BioSpectrum Asia

Ono partners with Ionis for sapablursen - The Pharma Letter

Wed, 12 Mar 2025 07:00:00 GMT

Ono partners with Ionis for sapablursen The Pharma Letter

Ionis Expecting Big Year Via Commercialization Partnerships, Independent Launches - San Diego Business Journal

Thu, 10 Apr 2025 07:00:00 GMT

Ionis Expecting Big Year Via Commercialization Partnerships, Independent Launches San Diego Business Journal

Vanderbilt, Ono Pharmaceutical sign drug discovery agreement - Vanderbilt Health News

Thu, 10 Dec 2015 08:00:00 GMT

Vanderbilt, Ono Pharmaceutical sign drug discovery agreement Vanderbilt Health News

ONO PHARMA USA Appoints David Trexler as Chief Commercial Officer - citybiz

Tue, 28 Sep 2021 07:00:00 GMT

ONO PHARMA USA Appoints David Trexler as Chief Commercial Officer citybiz

Bristol Myers, AstraZeneca settle PD-1, CTLA-4 cancer immunotherapy patent suits for $510M - Fierce Pharma

Tue, 01 Aug 2023 07:00:00 GMT

Bristol Myers, AstraZeneca settle PD-1, CTLA-4 cancer immunotherapy patent suits for $510M Fierce Pharma

LigaChem Biosciences, Ono Pharmaceutical ink $700 mn deal - 매일경제

Fri, 11 Oct 2024 07:00:00 GMT

LigaChem Biosciences, Ono Pharmaceutical ink $700 mn deal 매일경제

Numab Therapeutics extends partnership with Ono Pharmaceutical - Startupticker.

Wed, 14 Feb 2024 08:00:00 GMT

Numab Therapeutics extends partnership with Ono Pharmaceutical Startupticker.

Nobel winner Honjo wins huge settlement with drug giant - 朝日新聞

Sat, 13 Nov 2021 08:00:00 GMT

Nobel winner Honjo wins huge settlement with drug giant 朝日新聞

AstraZeneca faces $278M Imfinzi patent infringement lawsuit from co-developer Ono - Fierce Pharma

Tue, 01 Mar 2022 08:00:00 GMT

AstraZeneca faces $278M Imfinzi patent infringement lawsuit from co-developer Ono Fierce Pharma

Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field - PR Newswire

Thu, 09 Nov 2017 08:00:00 GMT

Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field PR Newswire

Array BioPharma And Ono Pharmaceutical Co., Ltd. Announce A License, Development And Commercialization Partnership For Two Novel Oncology Compounds, Binimetinib And Encorafenib - PR Newswire

Wed, 31 May 2017 07:00:00 GMT

Array BioPharma And Ono Pharmaceutical Co., Ltd. Announce A License, Development And Commercialization Partnership For Two Novel Oncology Compounds, Binimetinib And Encorafenib PR Newswire

Nobel laureate behind Bristol-Myers' I-O superstar Opdivo demands a bigger cut - Fierce Pharma

Thu, 11 Apr 2019 07:00:00 GMT

Nobel laureate behind Bristol-Myers' I-O superstar Opdivo demands a bigger cut Fierce Pharma

Extensions of term for patents covering multiple approved pharmaceutical substances clarified - Corrs Chambers Westgarth

Thu, 24 Mar 2022 07:00:00 GMT

Extensions of term for patents covering multiple approved pharmaceutical substances clarified Corrs Chambers Westgarth

Ono Pharmaceutical Hits Day Low of JPY 2,432.50 Amid Price Pressure - MarketsMojo

Tue, 19 May 2026 15:15:44 GMT

Ono Pharmaceutical Hits Day Low of JPY 2,432.50 Amid Price Pressure MarketsMojo